arrow
G

Gerd Geißlinger

Institute of Clinical Pharmacology
H指数:87
被引数:3.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Modest improvement of metabolic and behavioral deficits with long-term ambroxol treatment in a Pink1−/−SNCAA53T double mutant mouse model of Parkinson’s disease

帕金森病Pink1−/−SNCAA53T双突变小鼠模型中,长期阿莫西醇治疗对代谢和行为缺陷的轻微改善

2025-12-080
OAAI
Effect of thyme-ivy syrup on antiviral immune response in patients with mild COVID-19: a prospective; open-label; randomized pilot study

鼠尾草-常春藤糖浆对轻度COVID-19患者抗病毒免疫反应的影响:一项前瞻性、开放标签、随机试点研究

2025-10-220
OAAI
Elevated hexosylceramides in Parkinson’s disease cause gene upregulations in neurons mimicking responses to pathogens

帕金森病中升高的己糖基神经酰胺会导致神经元中基因上调,模拟对病原体的反应。

2025-08-300
OAAI
Novel aryl hydrocarbon receptor agonists as potential anti-inflammatory therapeutics: Identification and validation through drug repurposing

新型芳基羟碳受体激动剂作为潜在的抗炎治疗药物:通过药物重定位进行识别和验证

2025-06-240
PRE
Analysis of fatty acid-derived lipids in critically ill patients after cardiac surgery yields novel pathophysiologically relevant mediators with possible relevance for systemic inflammatory reactions
2025-01-070
OAAI
The endocannabinoid anandamide mediates anti-inflammatory effects through activation of NR4A nuclear receptors
2024-11-190
OAAI
SPMs exert anti- inflammatory and pro- resolving effects through positive allosteric modulation of the prostaglandin EP4 receptor
2024-10-043
OAAI